These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 38657989)

  • 1. Does worsening metabolic syndrome increase the risk of developing cancer?
    Saudi Med J; 2024 Apr; 45(4):446. PubMed ID: 38657989
    [No Abstract]   [Full Text] [Related]  

  • 2. Epidemiology and molecular mechanisms tying obesity, diabetes, and the metabolic syndrome with cancer.
    Gallagher EJ; LeRoith D
    Diabetes Care; 2013 Aug; 36 Suppl 2(Suppl 2):S233-9. PubMed ID: 23882051
    [No Abstract]   [Full Text] [Related]  

  • 3. Symposium introduction: metabolic syndrome and the onset of cancer.
    Zhou JR; Blackburn GL; Walker WA
    Am J Clin Nutr; 2007 Sep; 86(3):s817-9. PubMed ID: 18265474
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabolic syndrome and risk of cancer: a systematic review and meta-analysis.
    Esposito K; Chiodini P; Colao A; Lenzi A; Giugliano D
    Diabetes Care; 2012 Nov; 35(11):2402-11. PubMed ID: 23093685
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metabolic syndrome and cancer risk: The role of xanthine oxidoreductase.
    Battelli MG; Bortolotti M; Polito L; Bolognesi A
    Redox Biol; 2019 Feb; 21():101070. PubMed ID: 30576922
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epidemiology, trends, and morbidities of obesity and the metabolic syndrome.
    Bray GA; Bellanger T
    Endocrine; 2006 Feb; 29(1):109-17. PubMed ID: 16622298
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metabolic syndrome, obesity and cancer risk.
    Belladelli F; Montorsi F; Martini A
    Curr Opin Urol; 2022 Nov; 32(6):594-597. PubMed ID: 36081396
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metabolic dysfunction-associated fatty liver disease and the risk of 24 specific cancers.
    Liu Z; Lin C; Suo C; Zhao R; Jin L; Zhang T; Chen X
    Metabolism; 2022 Feb; 127():154955. PubMed ID: 34915036
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Unhealthy diets: a common soil for the association of metabolic syndrome and cancer.
    Esposito K; Ciardiello F; Giugliano D
    Endocrine; 2014 May; 46(1):39-42. PubMed ID: 24408049
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The influence of metabolic syndrome on gastric cancer: A meta-analysis.
    Luo Y; Liu JS; Dai B; Qian K
    Asian J Surg; 2021 Dec; 44(12):1596-1597. PubMed ID: 34511362
    [No Abstract]   [Full Text] [Related]  

  • 11. Prevalence of the metabolic syndrome in relation to self-reported cancer history.
    Ness KK; Oakes JM; Punyko JA; Baker KS; Gurney JG
    Ann Epidemiol; 2005 Mar; 15(3):202-6. PubMed ID: 15723765
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lifestyles, health habits, and prostate cancer.
    Kawada T
    J Cancer Res Clin Oncol; 2020 Jun; 146(6):1623-1624. PubMed ID: 30790052
    [No Abstract]   [Full Text] [Related]  

  • 13. COVID-19 and metabolic syndrome: could diet be the key?
    Demasi M
    BMJ Evid Based Med; 2021 Feb; 26(1):1-2. PubMed ID: 32651302
    [No Abstract]   [Full Text] [Related]  

  • 14. Metabolic syndrome and stroke.
    Towfighi A; Ovbiagele B
    Curr Diab Rep; 2008 Feb; 8(1):37-41. PubMed ID: 18366997
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metabolic syndrome: maladaptation to a modern world.
    Wilkin TJ; Voss LD
    J R Soc Med; 2004 Nov; 97(11):511-20. PubMed ID: 15520144
    [No Abstract]   [Full Text] [Related]  

  • 16. Metabolic syndrome as cardiovascular risk factor in childhood cancer survivors.
    Pluimakers VG; van Waas M; Neggers SJCMM; van den Heuvel-Eibrink MM
    Crit Rev Oncol Hematol; 2019 Jan; 133():129-141. PubMed ID: 30661649
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Point: the metabolic syndrome still lives.
    Grundy SM
    Clin Chem; 2005 Aug; 51(8):1352-4. PubMed ID: 16040840
    [No Abstract]   [Full Text] [Related]  

  • 18. Metabolic syndrome.
    Dominiczak MH
    Curr Opin Lipidol; 2003 Jun; 14(3):329-32. PubMed ID: 12840663
    [No Abstract]   [Full Text] [Related]  

  • 19. [Hyperleptinemia, hyperinsulinemia and metabolic syndrome in cardiovascular risk: one for all and all for one].
    Botella Carretero JI
    Med Clin (Barc); 2004 Dec; 123(20):780-1. PubMed ID: 15607071
    [No Abstract]   [Full Text] [Related]  

  • 20. Metabolic syndrome in an Asian Chinese population and agents and targets for cardiovascular protection.
    Fung ML; Wong TM
    Cardiovasc Hematol Disord Drug Targets; 2007 Jun; 7(2):77-8. PubMed ID: 17584041
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.